Lakefront Biotherapeutics | GLPG - EPS Earnings Per Share


Lakefront Biotherapeutics reported EUR-0.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.65 -3.07 Nov/12
FY2026Q1 Jun/2026 -0.20 -0.60 -1.58 Aug/10
FY2026Q1 Mar/2026 0.21 -1.21 -2.35 May/06
FY2025Q4 Dec/2025 11.89 -0.17 0.29 Feb/23
FY2025Q3 Sep/2025 -3.07 -0.41 -0.74 Nov/05




Eps Change Date
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Merck EUR -0.54 2.65 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.46 0.05 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026